NCT07304050 Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric
| NCT ID | NCT07304050 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Clinical Deterioration |
| Study Type | INTERVENTIONAL |
| Enrollment | 375 participants |
| Start Date | 2026-02-09 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 375 participants in total. It began in 2026-02-09 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effectiveness and user satisfaction of the study teams early warning system, called PICTURE, which utilizes artificial intelligence (AI) techniques and algorithms to identify patient deterioration on pediatric units within Mott Children's Hospital. In this pilot study the patient care team will review the PICTURE information and alerts. Morning rounds will be partially informed by the PICTURE scores and the scores will be included in the hand off notes for the patients with a red score. The primary purpose of this study is to test the hypothesis that the combination of the PICTURE-Pediatric model, the proposed workflow and the proposed interface results in at least 80% compliance. No participants will be consented as the Institutional review board has approved a waiver of consent for THE clinicians and the patients information being reviewed. The enrollment numbers will include only the clinicians.
Eligibility Criteria
Inclusion Criteria - Patients: * Age ≥30 days and ≤25 years * Be on the general care wards of Mott Children's Hospital or boarding in the Emergency Department (ED), but admitted to a pediatric floor medical team. These will be enforced by these criteria: 1. Patient class: not emergency b. Patient level of care: not Intensive Care unit (ICU) c. Patient locations (per protocol) Exclusion Criteria - Patients: * Patients that do not meet the inclusion criteria
Contact & Investigator
Rodney Daniels
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT07304050 clinical trial?
This trial is open to participants of all sexes, aged 30 Days or older, up to 25 Years, studying Clinical Deterioration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07304050 currently recruiting?
Yes, NCT07304050 is actively recruiting participants. Contact the research team at jsemerad@umich.edu for enrollment information.
Where is the NCT07304050 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT07304050 clinical trial?
NCT07304050 is sponsored by University of Michigan. The principal investigator is Rodney Daniels at University of Michigan. The trial plans to enroll 375 participants.